← SynDRA
7-ETHYL-10-HYDROXYCAMPTOTHECIN
SynDRA canonical compound SYN0002131 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | TOP1 |
| Mechanism of action | Topoisomerase inhibitor |
| Indication | colorectal cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- topoisomerase inhibitor
- TOP1 INHIBITOR
- DNA topoisomerase I inhibitor
Cross-references
Synonyms
- 7-ethyl-10-hydroxy-camptothecin
- Camptothecin, 7-ethyl-10-hydroxy-
- IT-141
- NK012
- NK-012
- SN-38
- SN38
- Irinotecan related compound b
- LE-SN38
- SN 38
- SN 38 lactone
- 7-Ethyl-10-hydroxy camptothecin
- 10-Hydroxy-7-ethylcamptothecin
- 7-Ethyl-10-hydroxycamptothecine
- 7-Ethyl-10-hydroxy-20(S)-camptothecin
- UNII-0H43101T0J
- Captothecin, 7-ethyl-10-hydroxy-
- CHEBI:8988
- (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- NSC673596
- 0H43101T0J
- (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN
- NK 012
- CAMPTOTHECIN, 7-ETHYL-10-HYDROXY-
- RefChem:914300
- DTXCID2020399
- 7-Ethyl-10-hydroxy-camptothecin
- MFCD00871873
- C22H20N2O5
- 7-10-hydroxycamptothecin
- AvaChem1025
- SN-38 (Standard)
- diethyl(dihydroxy)[?]dione
- SCHEMBL34018
- GTPL6925
- orb1307686
- orb3141304
Look up 7-ETHYL-10-HYDROXYCAMPTOTHECIN in the interactive SynDRA portal →